Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037452 · ClinicalTrials.gov registry record · Phase 2
Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn
A Phase 2 study, sponsored by Novartis.
- Completed
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT01037452 is a Phase 2 study that has completed, run by Novartis. The registered enrollment target is 120 participants.
The verdict
NCT01037452, a Phase 2 study, has completed, sponsored by Novartis.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will investigate the safety and efficacy of an antacid/Lansoprazole combination product for the relief of heartburn after consuming a heartburn-inducing meal.
Interventions
- DRUG Placebo
- DRUG Lansoprazole
- DRUG Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg
- DRUG Calcium carbonate/magnesium hydroxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01037452
The ClinicalTrials.gov registry entry for NCT01037452 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis, which has 265 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT01037452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01037452 about?
NCT01037452 is a clinical study titled "Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of Heartburn". This study will investigate the safety and efficacy of an antacid/Lansoprazole combination product for the relief of heartburn after consuming a heartburn-inducing meal.
What is the current status of trial NCT01037452?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2009-12.
What interventions are being tested in trial NCT01037452?
The interventions under investigation include: Placebo (DRUG), Lansoprazole (DRUG), Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg (DRUG), Calcium carbonate/magnesium hydroxide (DRUG).
Who is sponsoring clinical trial NCT01037452?
This trial is sponsored by Novartis, which has 265 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.